Not applicableStudy completedNCT04389827What this trial is testingGlobal Kidney Patient Trials NetworkWho this might be right forKidney Diseases The George Institute 5,999
Not applicableLooking for participantsNCT01605266What this trial is testingINSIGHT (Insight Into Nephrotic Syndrome)Who this might be right forNephrotic Syndrome The Hospital for Sick Children 1,000
Not applicableLooking for participantsNCT05036850What this trial is testingChina Kidney Patient Trials NetworkWho this might be right forKidney Diseases George (Beijing) Clinical Research Co. Ltd. 1,200
Not applicableLooking for participantsNCT03929887What this trial is testingKOrea Renal Biobank NEtwoRk System TOward NExt-generation AnalysisWho this might be right forGlomerular DiseaseMinimal Change DiseaseIgA Nephropathy+4 more Seoul National University Hospital 3,000
Testing effectiveness (Phase 2)Ended earlyNCT04387448What this trial is testingTRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change DiseaseWho this might be right forKidney DiseasesDiabetic NephropathiesGlomerulosclerosis, Focal Segmental+8 more Goldfinch Bio, Inc. 96
Large-scale testing (Phase 3)UnknownNCT03298698What this trial is testingEfficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic SyndromeWho this might be right forIdiopathic Nephrotic SyndromeMinimal Change DiseaseFocal Segmental Glomerulosclerosis Radboud University Medical Center 40
Not applicableLooking for participantsNCT05650619What this trial is testingRecurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change DiseaseWho this might be right forFocal Segmental GlomerulosclerosisMinimal Change DiseaseFSGS+1 more University of Michigan 300
Not applicableStudy completedNCT04369183What this trial is testingRituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change DiseaseWho this might be right forFocal Segmental GlomerulosclerosisMinimal Change Disease Istanbul University 25
Not applicableEnded earlyNCT04235621What this trial is testingUnderstand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)Who this might be right forGlomerulosclerosis, Focal SegmentalMinimal Change DiseaseDiabetic Nephropathies Goldfinch Bio, Inc. 20
Not applicableUnknownNCT03068572What this trial is testingDiagnostic Value of Linked Color Imaging for Minimal Change Esophagitis in Nonerosive Reflux Esophagitis and GERDWho this might be right forGastroesophageal Reflux DiseaseMinimal Change DiseaseNon-Reflux Esophagitis Affiliated Hospital to Academy of Military Medical Sciences 90
Not applicableNot Yet RecruitingNCT06315504What this trial is testingCirculating Factors in Nephrotic SyndromeWho this might be right forNephrotic SyndromeMembranous NephropathyMinimal Change Disease+1 more Iain Bressendorff 104
Large-scale testing (Phase 3)Looking for participantsNCT07499700What this trial is testingA Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental GlomerulosclerosisWho this might be right forMinimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS) Bio-Thera Solutions 192
Testing effectiveness (Phase 2)Study completedNCT04009668What this trial is testingTumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change DiseaseWho this might be right forFSGSMCDFocal Segmental Glomerulosclerosis+1 more University of Michigan 7
Testing effectiveness (Phase 2)Looking for participantsNCT06466135What this trial is testingStudy of WAL0921 in Patients With Glomerular Kidney DiseasesWho this might be right forDiabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more Walden Biosciences 96
Post-approval studies (Phase 4)Study completedNCT03210688What this trial is testingActive Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change NephropathyWho this might be right forMinimal Change DiseaseNephrotic Syndrome University of Aarhus 71
Large-scale testing (Phase 3)Study completedNCT01268033What this trial is testingEfficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During ChildhoodWho this might be right forChildhood Idiopathic Nephrotic Syndrome University Hospital, Limoges 26
Not applicableStudy completedNCT07702981What this trial is testingImmunophenotyping Profiling in Patients With Primary Nephrotic SyndromeWho this might be right forMembranous NephropathyMinimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS) University Hospital, Ioannina 40
Testing effectiveness (Phase 2)Looking for participantsNCT06500702What this trial is testingEvaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change DiseaseWho this might be right forFocal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion Sanofi 84
Large-scale testing (Phase 3)Not Yet RecruitingNCT06405100What this trial is testingEfficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCDWho this might be right forMinimal Change Disease Air Force Military Medical University, China 81
Not applicableUnknownNCT06443034What this trial is testingPredictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1Who this might be right forNephrotic SyndromeFocal Segmental GlomerulosclerosisAPOL1 Associated Kidney Disease Assistance Publique - Hôpitaux de Paris 124